ArticleBMC cardiovascular disorders2026
Congenital heart disease and folate pathway gene polymorphisms: findings from a North Indian cohort.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFolate plays a critical role in DNA synthesis, fetal development, and epigenomic regulation and its deficiencies can lead to several health defects, including adverse pregnancy outcomes and congenital heart defects (CHDs). Folic acid supplementation represents a low-cost, high-impact preventive strategy in maternal and child health, with particular relevance for underserved and high-risk populations.
methodFive one carbon metabolism gene variants (rs1801131, rs1801133 of MTHFR; rs1805087 of MTR; rs526934 of TCN1; rs2236225 of MTHFD1) with minor allele frequency > 0.1 were genotyped in 674 non-syndromic CHD cases (including 449 families) and 356 pooled controls. The data were analyzed for case–control associations, parental transmission patterns, and correlations with nutritional status.
resultsAmong the genetic variants analyzed, rs2236225 showed a strong allelic association with congenital heart disease (CHD) across all cases (A vs. G, p = 0.0003; OR = 1.4 [95% CI: 1.17–1.69]). This association was primarily driven by the ‘A’ allele, which emerged as a significant risk factor, especially within the acyanotic subgroup (A vs. G, p = 0.0001; OR = 1.47 [95% CI: 1.20–1.79]), and more specifically in ventricular septal defect (VSD) cases (A vs. G, p = 0.0003; OR = 1.5 [95% CI: 1.20–1.89]). A homozygous excess of genotypes was observed in Acyanotic group (AA vs GG, p = 0.0001; OR = 2.27[95% CI: 1.5─3.43]. Other Allelic association with ASD (p = 0.04); TOF (p = 0.02) and cyanotic group (p = 0.05) along with other genetic models was also noted. These findings underscore the potential involvement of rs2236225 in CHD pathogenesis and warrant further investigation into its clinical relevance. The MTHFR haplotype rs1801131–rs1801133 (CA) showed a significant association with CHD in both case–control and transmission disequilibrium analyses (p = 0.03), although neither SNP was independently significant. The common allele of rs1805087 was associated with CHD overall (p = 0.007; AG vs. AA), with a stronger effect observed in cyanotic cases (p = 0.005). Furthermore, this allele showed significant associations with maternal transmission (p = 0.01) and folic acid supplementation (p = 0.02), suggesting a gene-environment interaction. The rare allele of rs526934 exibited a dominant effect in acyanotic CHD cases (GG + AG vs. AA, p = 0.004). It also showed significant associations under a dominant model in VSD (p = 0.01) and ASD (p = 0.03).
conclusionThis dual-model study from North India offers a comprehensive evaluation of functional folate pathway gene variants in a large CHD cohort and suggest a complex interplay between genetic susceptibility and environmental factors, supporting a polygenic or gene–environment interaction model. Further validation in larger, well-characterized cohorts, incorporating additional variants, is essential to clarify the contribution of folate pathway polymorphisms to CHD aetiology.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.